Autologous stem-cell transplantation in Hodgkin's lymphoma: analysis of a therapeutic option.

@article{Arantes2011AutologousST,
  title={Autologous stem-cell transplantation in Hodgkin's lymphoma: analysis of a therapeutic option.},
  author={Adriano de Moraes Arantes and Frederico S. Teixeira and Tathiana Maia Al Ribaie and Luciana Lobo Duartec and Cl{\'a}udia Regina Abreu Silva and C. A. Z. Bariani},
  journal={Einstein},
  year={2011},
  volume={9 2},
  pages={
          124-9
        }
}
OBJECTIVE To report the clinical progress of patients with Hodgkin's lymphoma treated with autologous transplantation after failure or relapse of first-line treatment with chemotherapy and/or radiation therapy. METHODS The results of a retrospective analysis of 31 patients submitted to autologous transplantation as second-line treatment, between April 2000 and December 2008, were analyzed. Fourteen men and seventeen women, with a median age of 27 years, were submitted to autologous… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000